Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Amgen Inc.
  6. News
  7. Sector news
    AMGN   US0311621009

AMGEN INC.

(AMGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Other Pharmaceuticals
10/15S&P 500 Posts 1.8% Weekly Gain, Strongest Since July, Amid Positive Start to Q3 Results..
MT
10/15JOHNSON & JOHNSON : COVID-19 Vaccine Booster Shot Receives FDA Advisory Panel Recommendati..
MT
10/15JOHNSON & JOHNSON : COVID-19 Vaccine Wins FDA Advisory Panel's Backing as Booster for Adul..
MT
10/15MODERNA : COVID SCIENCE-Statins may slightly lower COVID-19 death risk; using a different ..
RE
10/15JOHNSON & JOHNSON : Janssen Gets Positive Opinion on Lung Cancer Treatment From European M..
MT
10/15FDA PANEL BACKS JOHNSON & JOHNSON CO : Bloomberg
MT
10/15MODERNA : U.S. FDA delays decision on Moderna's COVID-19 vaccine for adolescents - WSJ
RE
10/15PRESS RELEASE : US FDA approves Roche's Tecentriq -2-
DJ
10/15PRESS RELEASE : US FDA approves Roche's Tecentriq as adjuvant treatment for certain people..
DJ
10/15MODERNA : U.S. FDA advisers to vote on J&J COVID-19 vaccine booster
RE
10/15GENENTECH : FDA Approves Tecentriq as Adjuvant Treatment for Certain Lung Cancer Patients
DJ
10/15PFIZER : BioNTech Makes European Medicines Agency Submission of Data Focusing COVID-19 Vac..
MT
10/15BIONTECH : Pfizer Seek European Medicines Agency's Approval for COVID-19 Vaccine for Young..
MT
10/15PRO BANKRUPTCY BRIEFING : J&J Unit Files Bankruptcy Over Talc Claims; Purdue Appeals to Be..
DJ
10/15PFIZER : Abrocitinib Receives Positive Opinion From European Regulator
MT
10/15Pfizer Gets Positive CHMP Opinion for Abrocitinib in Atopic Dermatitis
DJ
10/15JOHNSON & JOHNSON : Talc Claims Unit Files for Chapter 11 Bankruptcy; Company to Set Up $2..
MT
10/15CSL : Reaffirms Commitment to Manufacture 50 Million Doses of AstraZeneca Vaccine
MT
10/15ASTRAZENECA : France Sends AstraZeneca's COVID-19 Jabs to Nigeria Under COVAX
MT
10/15ROCHE : Joins PathAI to Develop AI-Based Image Analysis Workflow for Pathologists
MT
10/15US to Donate Over 17 Million Doses of Johnson & Johnson's COVID-19 Jab to African Union
MT
10/15PRESS RELEASE : Roche announces PathAI collaboration for artificial intelligence-based dig..
DJ
10/14ELI LILLY AND : Releases Updated Data From Phase 3 Breast Cancer Trial
MT
10/14ROCHE : U.S. FDA advisers to review Merck's oral COVID-19 drug next month
RE
10/14ROCHE : AlphaValue/Baader Europe Lifts Price Target on Roche, Maintains Add Recommendation
MT
10/14NOVO NORDISK : Buy rating from Goldman Sachs
MD
10/14ROCHE HOLDINGS AG : Goldman Sachs reaffirms its Buy rating
MD
10/14ROCHE : Scores Wins In Blood Cancer, Rare Nervous Disorder Therapeutic Areas
MT
10/14ROCHE HOLDINGS AG : Buy rating from Bernstein
MD
10/14ROCHE : Rare Central Nervous System Disease Therapy Reduces Relapses In Patients
MT
10/14ROCHE : Wins EU Nod For Shorter Gazyvaro Infusion Time in Follicular Lymphoma Patients
MT
10/14PRESS RELEASE : New four-year data show Roche's -2-
DJ
10/14PRESS RELEASE : New four-year data show Roche's ENSPRYNG significantly reduces debilitatin..
DJ
10/14Roche Holding Ag Announces New Longer-Term Efficacy and Safety Data for ENSPRYNG
CI
10/14PRESS RELEASE : Roche's Gazyvaro shorter 90-minute -2-
DJ
10/14PRESS RELEASE : Roche's Gazyvaro shorter 90-minute infusion time approved in Europe for pe..
DJ
10/14Roche’s Gazyvaro Shorter 90-Minute Infusion Time Gets Approval in Europe for People wit..
CI
10/13Australia's CSL reaffirms commitment to making AstraZeneca COVID vaccine
RE
10/13Australia's CSL reiterates manufacturing commitment with AstraZeneca COVID-19 vaccine
RE
10/13MODERNA : J&J COVID-19 shot gets better boost from Moderna or Pfizer in NIH study
RE
10/13AGILENT TECHNOLOGIES : Eli Lilly Get FDA's OK for Assay to Identify Early Breast Cancer
MT
10/13MODERNA : FDA scientists' analysis of J&J COVID-19 booster data raises red flags
RE
10/13Moderna, Pfizer Booster Shots More Effective Than J&J Extra Dose, NIH Study Reportedly ..
MT
10/13ROCHE HOLDINGS AG : JP Morgan reiterates its Neutral rating
MD
10/13ASTRAZENECA : Russia says Sputnik Light is 70% effective against Delta variant
RE
10/13ROCHE HOLDINGS AG : Morgan Stanley reiterates its Neutral rating
MD
10/13Johnson & Johnson Appoints Jessica Moore as Vice President of Investor Relations
CI
10/13Merck KGaA's Multiple Sclerosis Treatment Drug Shows Improved Quality Of Life In Study
MT
10/13ELI LILLY AND : Combination Therapy Receives FDA Approval as Adjuvant Treatment for Certai..
MT
10/13FDA Approves Verzenio« (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain..
CI
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on AMGEN INC.
11/02/21